At a glance
A liquid biopsy is a blood test that searches for fragments of cancer DNA and cancer cells that have broken away from a tumour and entered the bloodstream.
When a tumour grows, tiny pieces of its genetic material, called circulating tumour DNA (ctDNA), spill into the blood. A laboratory analyses a small blood sample to detect these fragments, identify mutations (changes in the genes) that are driving the cancer, and sometimes spot cancer before a lump is even visible on a scan. Because only a needle and a blood tube are needed, the whole collection takes a few minutes and causes no more discomfort than a routine blood draw.
Medical Condition
Liquid biopsy is used across many cancer types and at several points during a patient's care, from first suspicion through to monitoring after treatment.
- Detecting specific gene mutations in confirmed cancers such as lung, breast, colorectal, and prostate cancer, to guide which targeted therapy to use.
- Monitoring how well treatment is working: falling ctDNA levels usually mean the cancer is responding, while rising levels can signal resistance.
- Detecting cancer that has come back (recurrence) after surgery or other treatment, often weeks before it would appear on a scan.
- Identifying additional mutations that appear when a cancer becomes resistant to a drug, so treatment can be changed.
- Early detection screening in people at high inherited risk of cancer, in clinical trial settings.
- Situations where a standard tissue biopsy (removing a piece of the tumour through surgery or a needle) is too risky or technically difficult because of the tumour's location.
Liquid biopsy is not suitable for every situation. Its ability to detect cancer depends heavily on how much ctDNA the tumour is shedding, which varies by cancer type, stage, and individual biology. A negative result does not always mean there is no cancer.
- Very early-stage cancers may shed too little DNA for current tests to detect reliably.
- Some cancer types shed very low amounts of ctDNA, reducing the test's sensitivity.
- It cannot replace tissue biopsy for the initial diagnosis when a full pathological assessment (examining the tissue under a microscope) is needed.
- Results must always be interpreted alongside imaging, tissue findings, and clinical judgment, not in isolation.
Risks & Complications
Because liquid biopsy involves nothing more than drawing blood from a vein, its physical risks are minimal and the same as any standard blood test.
- Brief pain or discomfort at the needle site during the draw.
- A small bruise or mild swelling at the puncture point, which usually fades within a day or two.
- Rarely, a small collection of blood under the skin (haematoma) at the needle site.
- Very rarely, light-headedness or fainting, particularly in patients who are anxious about needles.
- A meaningful but non-physical risk: a false-negative result, where the test does not detect cancer that is present, potentially delaying further investigation.
- A false-positive result, where fragments detected may not reflect active cancer, potentially leading to unnecessary anxiety or additional tests.
Preparation & Procedure
Liquid biopsy requires very little preparation compared with surgical procedures, but a few steps help ensure the sample is usable and the result is accurate.
Most laboratories do not require fasting before a liquid biopsy, but the requesting oncologist (cancer specialist) may advise otherwise if other blood tests are being done at the same time. Patients do not usually need to stop any medications before the draw, though the doctor should be told about all current medicines, supplements, and herbal products. Smoking and alcohol do not directly affect ctDNA levels, but patients are generally encouraged to follow their usual cancer-care instructions.
Before the draw, the laboratory may run or request a baseline panel of standard blood tests to assess overall health and to provide context for the liquid biopsy result. Genetic counselling (a session to explain what the results might mean for the patient and family) is sometimes offered before and after testing, especially when inherited cancer risk is being assessed.
- 1. A nurse or phlebotomist (blood-drawing specialist) cleans the skin over a vein, usually in the inner elbow.
- 2. A thin needle is inserted into the vein and the required volume of blood is drawn into one or more special collection tubes.
- 3. The needle is removed and light pressure is applied to stop any bleeding.
- 4. The tubes are labelled and sent to a specialist molecular laboratory, often within a strictly timed window to preserve DNA quality.
- 5. In the laboratory, the blood is processed to isolate ctDNA or circulating tumour cells (CTCs, whole cancer cells in the blood).
- 6. Advanced genetic sequencing or other molecular analysis techniques examine the isolated material for cancer-associated changes.
- 7. A pathologist or molecular biologist interprets the findings and issues a report, which the oncologist then discusses with the patient.
Aftercare
Recovery after a liquid biopsy is immediate. Patients can eat, drink, drive, and return to all normal activities straight away, because the only physical event is a blood draw.
- Keep the small plaster or bandage on the needle site for at least an hour to prevent bruising.
- If a bruise or tender spot develops, a cool cloth applied gently to the area can help.
- No wound care, activity restrictions, or dietary changes are needed after the blood draw itself.
- Results typically take one to three weeks depending on the laboratory and the complexity of the analysis; ask the ordering doctor for the expected turnaround at your specific facility.
- A follow-up appointment with the oncologist is usually scheduled to go through the results, which require specialist interpretation and should not be read in isolation.
- If the test was ordered to monitor an ongoing treatment, repeat liquid biopsies may be scheduled at regular intervals, and the oncologist will explain the plan.
- Genetic counselling after results is recommended when the findings have implications for inherited cancer risk in the patient's family.
Cost & What Determines It
The price of a liquid biopsy varies widely because the test is not a single standardised assay. Different panels examine different numbers of genes, use different technologies, and require different levels of laboratory expertise.
- Scope of the genetic panel: a test looking at a handful of known mutations costs less than one that sequences hundreds of genes or the whole cancer genome.
- Technology used: standard PCR-based tests (which detect known specific mutations) are generally less expensive than next-generation sequencing (NGS), which reads large stretches of DNA.
- Hospital or clinic class and country: laboratory fees and overhead costs differ significantly between countries and between private, university, and public hospitals.
- Whether the test is done in-house or sent to a reference laboratory abroad, which adds courier costs and turnaround time.
- Number of repeat tests: if liquid biopsy is used to monitor treatment over many months, the total cost multiplies with each repeat.
- Any additional consultations, genetic counselling sessions, or interpretive reports billed alongside the laboratory fee.
- Urgency: expedited processing at some laboratories carries a premium.
A hospital package for liquid biopsy usually covers the blood draw, the laboratory processing and sequencing, and the written report. Genetic counselling, the oncologist consultation to discuss results, and any follow-on imaging or tissue biopsy triggered by the findings are almost always billed separately.
BPJS Kesehatan does not cover liquid biopsy performed abroad, and most Indonesian private insurance policies also exclude overseas treatment. Patients travelling for this test typically pay out of pocket or hold an international private health insurance policy that explicitly covers diagnostic testing outside Indonesia. Before travelling, ask the hospital for a written cost estimate that itemises the panel chosen, laboratory fees, consultation charges, and any courier or handling fees for the sample. This written quote is the most reliable way to avoid unexpected charges on arrival.
Frequently Asked Questions
Does a liquid biopsy hurt?
A liquid biopsy is just a standard blood draw, so most people feel only a brief pinch when the needle goes in. There is no cutting, no tissue removal, and no recovery time needed afterwards.
How do I prepare for a liquid biopsy? Do I need to fast?
In most cases, no special preparation is required, and fasting is not usually necessary. Your doctor may give you specific instructions depending on your overall health or any medications you take, so it is worth confirming with the clinic beforehand.
How long does a liquid biopsy take, and when will I get my results?
The blood draw itself takes only a few minutes. Processing the sample in the laboratory is the longer part, and results typically come back within one to two weeks, though some centres may take longer depending on the tests being run.
How much does a liquid biopsy cost?
The cost depends on how many cancer markers (specific genetic signals in the blood) are being tested, the technology the laboratory uses, and the type of hospital or clinic performing the analysis. Because these factors vary widely from one facility to another, a written estimate from the hospital is the most reliable way to get a real figure for your situation.
This page is general information, not a substitute for medical advice. Every case is different. Your doctor decides what is right for you.
